Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5701348 | Journal of Cancer Policy | 2017 | 17 Pages |
Abstract
We found just 40% (19/48) of drugs hailed as “unprecedented” were tested in a randomized trial where no superior study could be found or which did not fail in phase 3, and nearly half had not earned FDA approval. The use of the word “unprecedented” in the lay press is often inaccurate and frequently overstates the importance of findings from the scientific literature.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Kristy Tayapongsak Duggan, Kevin De Jesus, Robert Kemp, Vinay Prasad,